| Product Code: ETC13408498 | Publication Date: Apr 2025 | Updated Date: Sep 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 1.5 Billion |
| Forecast Size (2032) | USD 2.5 Billion |
| CAGR | 14.50% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Largest Segment | Kits and Reagents |
| Fastest Growing Segment | Assays |
| Leading Companies | Abbott Laboratories, Roche Diagnostics, BD, Siemens Healthineers, Cepheid |

The Global Infectious Disease Rapid Diagnostic Testing Market was estimated at USD 1.5 Billion in 2025 and is projected to reach USD 2.5 Billion by 2032, growing at a CAGR of 14.50% from 2026 to 2032.
The Global Infectious Disease Rapid Diagnostic Testing Market is transforming in response to the urgent need for timely disease identification and management. The surge in infectious diseases has prompted healthcare systems worldwide to prioritize rapid testing solutions, which facilitate quick decision-making for patient treatment and enhance disease control measures.
This market plays a crucial role in supporting various industries, particularly healthcare and public health sectors, where rapid results can lead to swift interventions. Key aspects differentiating this market from others include its focus on point-of-care testing and advancements in molecular diagnostics, making it indispensable for modern healthcare applications.
This graph illustrates the annual growth rates of the Global Infectious Disease Rapid Diagnostic Testing Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 8.36 | Healthcare providers are increasingly adopting rapid diagnostic testing to improve patient outcomes. |
| 2023 | 5.42 | Biosensor technology integration is attracting significant investment in the infectious disease diagnostics sector. |
| 2024 | 9.23 | Regulatory approvals streamlining processes enhance access to rapid diagnostic testing for healthcare facilities. |
| 2025 | 7.34 | A shift toward lower raw material costs reduces expenses for rapid diagnostic testing producers. |
| 2026 | 8.14 | In North America, supply chain dynamics are strengthening the availability of infectious disease testing products. |
| 2027 | 7.29 | Enhanced market accessibility drives regional expansion of rapid diagnostic testing solutions across Europe. |
| 2028 | 9.01 | While innovative diagnostic technologies emerge, rapid testing methods are becoming more accurate and efficient. |
| 2029 | 4.45 | Evolving patient demand for faster results is reshaping preferences in infectious disease diagnostic testing. |
| 2030 | 9.1 | Laboratory infrastructures are increasingly hiring skilled personnel to enhance rapid testing capabilities. |
| 2031 | 6.59 | Manufacturers are adapting strategies in response to shifting competitive pressures within the diagnostic testing sector. |
| 2032 | 8.49 | Sustainable manufacturing practices in rapid diagnostic testing contribute to reduced environmental impacts. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
Challenges faced by the Global Infectious Disease Rapid Diagnostic Testing Market include stringent regulatory requirements that can impede the speed of product approvals. For instance, obtaining FDA clearance can involve a timeline of 12 to 18 months, slowing down the pace at which new tests reach the market. This regulatory landscape creates barriers for innovative companies aiming to penetrate this rapidly evolving sector. Additionally, variations in testing accuracy, such as sensitivity rates that can differ by up to 15%, further create trust issues among clinicians and patients alike, compelling manufacturers to continuously enhance their product reliability.
Several operational and technological trends are reshaping the Global Infectious Disease Rapid Diagnostic Testing Market. One prominent trend is the shift towards mobile and point-of-care testing, reflected in initiatives like Abbott's ID NOW platform, which provides results for COVID-19 in under 15 minutes. This move towards decentralization of testing has been validated by increasing healthcare burdens and a necessity for rapid results. Another trend is the integration of artificial intelligence (AI) into diagnostics, with companies like Siemens Healthineers adopting AI to enhance the accuracy of their tests. For example, the introduction of AI-enhanced processes led to a 30% reduction in false positives last year, emphasizing the pertinence of technological advancements in diagnostics.
The Global Infectious Disease Rapid Diagnostic Testing Market presents numerous opportunities, particularly as healthcare systems increasingly emphasize early diagnosis and disease management. A promising area lies in the expansion of product offerings, such as tests for emerging infectious diseases like monkeypox, highlighted by Cepheid's recent commitment to develop a suite of diagnostic tests set to launch by 2025. Furthermore, strategic partnerships are pivotal; for instance, Roche Diagnostics formed a collaboration with Moderna, aimed at developing comprehensive testing solutions for respiratory viruses, which shows potential to capture a significant market share. These initiatives underscore proactive moves to address evolving health threats effectively.
In the Global Infectious Disease Rapid Diagnostic Testing Market, the segment of Kits and Reagents holds the largest share, estimated at approximately 55% in 2025, owing to their widespread application in both clinical and home testing settings. Assays, however, are the fastest-growing segment, projected to achieve a CAGR of 22.0% from 2026 to 2032, driven by their enhanced specificity and rapid results, making them increasingly favored in point-of-care applications. The surge in demand for high-performance assays is fundamentally reshaping testing paradigms and elevating the standard in disease management.
The Immunodiagnostics technology segment is currently the largest in the Global Infectious Disease Rapid Diagnostic Testing Market, commanding approximately 45% market share in 2025. However, Clinical Microbiology is anticipated to be the fastest-growing technology segment, with a CAGR of 18.5% from 2026 to 2032. This growth is attributed to its effectiveness in diagnosing a wide range of infectious agents, particularly in resource-limited settings, thus expanding its utility across diverse healthcare environments. The increasing reliance on these technologies underpins further advancements and greater integration into public health frameworks.
Hospitals represent the largest end-user segment in the Global Infectious Disease Rapid Diagnostic Testing Market, with an estimated share of about 50% in 2025, driven by their capacity to ensure immediate and comprehensive patient care. Alternatively, academic and research institutes are expected to be the fastest growing segment, with a CAGR of 19.0% from 2026 to 2032. This growth is largely fueled by increased research initiatives aimed at understanding and combating infectious diseases, enhancing collaborative efforts between academia and healthcare providers for practical applications and innovations.
North America leads the Global Infectious Disease Rapid Diagnostic Testing Market with roughly 60% share in 2025, driven by advanced healthcare infrastructure, high research investment, and consumer access to rapid testing technologies. In contrast, the Asia-Pacific region is expected to demonstrate the fastest growth, with a CAGR of 20.5% from 2026 to 2032, fueled by electronic health initiatives and an expanding middle class that fosters increased healthcare spending. This combination of factors positions Asia-Pacific as a critical driver of future market dynamics.
The regulatory landscape surrounding the Global Infectious Disease Rapid Diagnostic Testing Market is characterized by active government involvement aimed at enhancing testing capabilities amid rising health threats. Various initiatives and policies have been instituted to promote research, ensure safety, and accelerate the introduction of rapid testing solutions to the market.
The Global Infectious Disease Rapid Diagnostic Testing Market is expected to undergo transformative changes influenced by emerging technologies and evolving healthcare needs. For instance, the integration of artificial intelligence into diagnostic procedures is anticipated to enhance test accuracy and reduce turnaround times significantly. Companies like Siemens Healthineers are already utilizing AI for optimizing diagnostic accuracy, evidenced by a reported 30% decrease in false positives. This trajectory highlights a focus on precision diagnostics while ensuring rapid test availability, aligning with greater healthcare demands through 2032.
Recent advancements in the Global Infectious Disease Rapid Diagnostic Testing Market are reshaping competitive dynamics and product offerings. The following developments are noteworthy:
The competitive landscape of the Global Infectious Disease Rapid Diagnostic Testing Market is relatively consolidated, with several major players dominating the sector. This consolidation fosters a robust environment for innovation and strategic partnerships, enabling companies to leverage resources for advanced product development.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Abbott Laboratories | Leading expertise in rapid testing solutions | Expansion of point-of-care capabilities |
| Roche Diagnostics | Strong focus on innovative platform development | Strategic acquisitions to enhance testing range |
| BD | Robust product portfolio in infectious disease testing | Enhancing multiplex testing capabilities |
| Siemens Healthineers | Advanced integration of AI in diagnostics | Focus on improving diagnostic accuracy |
| Cepheid | Rapid and reliable molecular testing solutions | Expansion into emerging infectious diseases |
As these companies continue to innovate and expand, their strategic choices will significantly impact the future trajectory of the market, particularly in responding to emerging health threats.
The Global Infectious Disease Rapid Diagnostic Testing Market report provides a detailed analysis of the following market segments:
Global Infectious Disease Rapid Diagnostic Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Infectious Disease Rapid Diagnostic Testing Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Global Infectious Disease Rapid Diagnostic Testing Market - Industry Life Cycle |
3.4 Global Infectious Disease Rapid Diagnostic Testing Market - Porter's Five Forces |
3.5 Global Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.7 Global Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.8 Global Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Global Infectious Disease Rapid Diagnostic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Infectious Disease Rapid Diagnostic Testing Market Trends |
6 Global Infectious Disease Rapid Diagnostic Testing Market, 2022-2032 |
6.1 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Product, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Assays, Kits and Reagents, 2022-2032 |
6.1.3 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Instruments, 2022-2032 |
6.1.4 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Services and Software, 2022-2032 |
6.2 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Technology, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Immunodiagnostics, 2022-2032 |
6.2.3 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Clinical Microbiology, 2022-2032 |
6.2.4 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By PCR, 2022-2032 |
6.2.5 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By INAAT, 2022-2032 |
6.2.6 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By DNA Sequencing and NGS, 2022-2032 |
6.2.7 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Other Technologies, 2022-2032 |
6.3 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By End-users, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Physician Offices, 2022-2032 |
6.3.3 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Reference Laboratories, 2022-2032 |
6.3.4 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Hospitals, 2022-2032 |
6.3.5 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Academic and Research Institutes, 2022-2032 |
6.3.6 Global Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Others, 2022-2032 |
7 North America Infectious Disease Rapid Diagnostic Testing Market, Overview & Analysis |
7.1 North America Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022-2032 |
7.2 North America Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
7.3 North America Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Product, 2022-2032 |
7.4 North America Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Technology, 2022-2032 |
7.5 North America Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By End-users, 2022-2032 |
8 Latin America (LATAM) Infectious Disease Rapid Diagnostic Testing Market, Overview & Analysis |
8.1 Latin America (LATAM) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Product, 2022-2032 |
8.4 Latin America (LATAM) Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Technology, 2022-2032 |
8.5 Latin America (LATAM) Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By End-users, 2022-2032 |
9 Asia Infectious Disease Rapid Diagnostic Testing Market, Overview & Analysis |
9.1 Asia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022-2032 |
9.2 Asia Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
9.2.2 China Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
9.3 Asia Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Product, 2022-2032 |
9.4 Asia Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Technology, 2022-2032 |
9.5 Asia Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By End-users, 2022-2032 |
10 Africa Infectious Disease Rapid Diagnostic Testing Market, Overview & Analysis |
10.1 Africa Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022-2032 |
10.2 Africa Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
10.3 Africa Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Product, 2022-2032 |
10.4 Africa Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Technology, 2022-2032 |
10.5 Africa Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By End-users, 2022-2032 |
11 Europe Infectious Disease Rapid Diagnostic Testing Market, Overview & Analysis |
11.1 Europe Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022-2032 |
11.2 Europe Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
11.2.3 France Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
11.3 Europe Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Product, 2022-2032 |
11.4 Europe Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Technology, 2022-2032 |
11.5 Europe Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By End-users, 2022-2032 |
12 Middle East Infectious Disease Rapid Diagnostic Testing Market, Overview & Analysis |
12.1 Middle East Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022-2032 |
12.2 Middle East Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Product, 2022-2032 |
12.4 Middle East Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By Technology, 2022-2032 |
12.5 Middle East Infectious Disease Rapid Diagnostic Testing Market, Revenues & Volume, By End-users, 2022-2032 |
13 Global Infectious Disease Rapid Diagnostic Testing Market Key Performance Indicators |
14 Global Infectious Disease Rapid Diagnostic Testing Market - Export/Import By Countries Assessment |
15 Global Infectious Disease Rapid Diagnostic Testing Market - Opportunity Assessment |
15.1 Global Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
15.3 Global Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
15.4 Global Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
16 Global Infectious Disease Rapid Diagnostic Testing Market - Competitive Landscape |
16.1 Global Infectious Disease Rapid Diagnostic Testing Market Revenue Share, By Companies, 2025 |
16.2 Global Infectious Disease Rapid Diagnostic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here